Professor Geoff Bellingan

Dr Geoff BellingTel: 020 3447 4552
Fax: 020 3447 0380
Email: geoff.bellingan@uclh.nhs.uk

Location:
University College Hospital

Specialities:
Critical care

Professional background

Currently Medical Director for Surgery and Cancer board, covering critical care, anaesthesia, theatres, sterile services and medical physics in the Division. I was previously the clinical director for critical care. I am also Reader in Intensive Care Medicine at UCL and theme lead for the critical care and anaesthesia research theme for the Comprehensive Biomedical Research Centre. I am a chest physician who works clinically only in critical care.

Research interests

My special interests are in Acute Respiratory Distress Syndrome (ARDS) and in sepsis and inflammation.

Publications

Publications for the last 5 years:

1.      Cuthbertson BH, Thompson M, Sherry A, Wright MM, Bellingan GJ. The Intensive Care Society (2004) Antibiotic-treated infections in intensive care patients in the UK. Anaesthesia 59; 885-890.

2.      RJ Hodges, RGi Jenkins, CP  Wheeler-Jones, SE Bottoms, GJ Bellingan, CB Nanthakumar, GJ Laurent, SL Hart, ML Foster and RJ McAnulty. (2004) Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol  165; 1663-76

3.      MA Elrayess; KE Webb, GJ Bellingan, RA Whittall, J Kabir, E Hawe, M Syvänne, M Taskinen, MH Frick, MS Nieminen, YA Kesäniemi, A Pasternack, GJ Miller, and SE Humphries. (2004) R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events. Atherosclerosis  . 177; 127-35.

4.      Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF, Witte MC, Richards GA, Rippin G, Rathgeb F, Hafner D, Taut FJ, Seeger W (2004)  Effect of Recombinant Surfactant Protein C Based Surfactant on Patients with the Acute Respiratory Distress Syndrome. N. Eng J. Med 351; 884-92.

5.      J. Cepeda, T. Whitehouse, B. Cooper, J. Hails, K. Jones, F. Kwaku, L. Taylor, S. Hayman, S. Shaw, M. Singer, G. Bellingan, P. Wilson (2005) Isolation of patients in single rooms or cohorts to reduce spread of MRSA in ICU: prospective two-centre study. Lancet 365:295-304.

6.      Ng J, Finney SJ, Shulman R, Bellingan GJ, Singer M, Glynne PA.  (2005) Treatment of pulmonary hypertension in the general adult intensive care unit: a role for oral sildenafil? Br J Anaesth 94; 774-7.

7.      G Bellingan (2005) Hooray for Hypoxia? PLoS Med 2(6): e130

8.      Tang J, Eames I, Li Y, Taha YA, Wilson P, Bellingan G, Ward K and Breur J. (2005) Door-opening motion can potentially lead to a transient breakdown in negative-pressure isolation conditions: the importance of vorticity and buoyancy airflows. J Hosp Infect 61; 283-6.

9.      RI Shulman, M Singer, J Goldstone and G Bellingan (2005) Medication errors: a prospective cohort study of hand-written and computerised physician order entry in the ICU. Crit Care. 5;9(5):R516-21

10.   Wilson, AP, Cepeda, JA, Hayman,S, Whitehouse,T, Singer,M, Bellingan,G. (2006).  In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients. Journal of  Antimicrobial Chemotherapy 58, 470-473

11.   Wilson AP, Hayman S, Folan P, Ostro PT, Birkett A, Batson S, Singer M, Bellingan G. (2006) Computer keyboards and the spread of MRSA. J Hosp Infect;62:390-2.

12.   Wilson AP, Hayman S, Cepeda JA, Singer M, Bellingan G. (2006) Screening for MRSA and GISA in the intensive care unit. J Hosp Infect. Jul 1; [Epub ahead of print]

13.   M Woodhead CA Welch, DA Harrison, G Bellingan and JG Ayres (2007) Community-acquired pneumonia on the intensive care unit: secondary analysis of 17,869 cases in the ICNARC Case Mix Programme. Critical Care;35:2275-9..

14.   Gibot,S., Massin,F., Marcou,M., Taylor,V., Stidwell,R., Wilson,P., Singer,M. Bellingan,G. (2007). TREM-1 promotes survival during septic shock in mice. European Journal of Immunology 37(2), 456-466.

15.   Hayman,S., Wilson,P., Singer,M., Bellingan,G. (2007). Effect of Linezolid and teicoplanin on skin staphylococci. Journal of Antimicrobial Chemotherapy  59, 1281-1282.

16.   Heightman,M., Bellingan,G. (2007). Acute respiratory medicine. Clinical Medicine 7(3), 267-271.

17.   Wilson,A.P., Hayman,S., Whitehouse,T., Cepeda,J., Kibbler,C., Shaw,S., Zelaya,C., Cookson,B., Singer,M., Bellingan,G. (2007). Importance of the  environment for patient acquisition of methicillin-resistant Staphylococcus aureus in the intensive care unit: a baseline study. Crit Care Med 35, 2275-2279.

18.   Rajakariar R, Hilliard M, Lawrence T, Trivedi S, Colville-Nash P, Bellingan G, Fitzgerald D, Yaqoob MM, Gilroy DW. (2007) Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc Natl Acad Sci U S A 104: 20979-84.

19.   Lagan AL, Quinlan GJ, Mumby S, Melley DD, Goldstraw P, Bellingan GJ, Hill MR, Briggs D, Pantelidis P, du Bois RM, Welsh KI, Evans TW.  (2008) Variation in iron homeostasis genes between patients with acute respiratory distress syndrome and healthy controls. Chest.;133:1302-11.

20.   Cordery RJ, Roberts CH, Cooper SJ, Bellinghan G, Shetty N. (2008). Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome. J Hosp Infect.;68:108-15. Epub 2007 Dec

21.   Rajakariar R, Lawrence T, Bystrom J, Hilliard M, Colville-Nash P, Bellingan G, Fitzgerald D, Yaqoob MM, Gilroy DW. (2008) Novel biphasic role for lymphocytes revealed during resolving inflammation. Blood;111:4184-92.

22.   P. Wilson, B. Cookson, J. Cepeda, G. Bellingan, J. Brown. (2008) Utility of spa typing for investigating the local epidemiology of MRSA on a UK intensive care ward. S. Khandavilli, J Hosp Infection (in press)
 

GMC/GDC number: 3168941